Verified ProfileEN

Xingyuan Avenue (Hengqin) Biotechnology Co., Ltd.

Order verification — $199

Scientific Research and Technical Services · Technology Promotion Services

Verification dossier

Xingyuan Avenue (Hengqin) Biotechnology Co., Ltd. is a Chinese company based in Zhuhai, Guangdong. The company operates in the technology promotion services sector, within the broader scientific research and technical services industry. Established 2025, the company has been operating for 1 years.

Sinolinks tracks Xingyuan Avenue (Hengqin) Biotechnology Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Licensed: Food sales; Class III medical device operation; online food sales; food production; health food production. General: Technology services and development; technology import and export; import and export of goods; health food (pre-packaged) sales; research and development of extraction, purification, and synthesis technologies for marine bioactive substances; sales of bio-based materials; R&D of bio-based materials; R&D of bio-pesticide technology; R&D of bio-based material polymerization technology; R&D of biomass energy technology; R&D of biochemical products; cosmetics wholesale and retail.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review